Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COCAR: Colchicine in CABG After ACS
NCT05726019Phase 2Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Feb 2022
- Primary completion
- Dec 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in acute coronary syndrome (ACS), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Feb 2022; status: completed.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT05726019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05726019.